248 related articles for article (PubMed ID: 22997451)
21. An analysis of adjuvant treatment strategies for carcinoma of the cervix.
Potish RA; Twiggs LB
Am J Clin Oncol; 1989 Oct; 12(5):430-3. PubMed ID: 2801604
[TBL] [Abstract][Full Text] [Related]
22. Selective therapy for early cancer of the cervix. I. Surgically explored nonresected cases.
Nordqvist SR; Jaramillo B; Ford JH; Averette HE
Gynecol Oncol; 1979 Apr; 7(2):248-56. PubMed ID: 437574
[No Abstract] [Full Text] [Related]
23. Functional imaging for assessing tumor response in cancer of the cervix.
Roberts C; Liyanage SH; Harry VN; Rockall AG
Womens Health (Lond); 2011 Jul; 7(4):487-97. PubMed ID: 21790341
[TBL] [Abstract][Full Text] [Related]
24. Adjuvant therapy after radical surgery for stage IB-IIB cervical adenocarcinoma with risk factors.
Seki T; Tanabe H; Nagata C; Suzuki J; Suzuki K; Takano H; Isonishi S; Ochiai K; Takakura S; Okamoto A
Jpn J Clin Oncol; 2017 Jan; 47(1):32-38. PubMed ID: 27677664
[TBL] [Abstract][Full Text] [Related]
25. Fine-needle aspiration biopsy in the management of cervical carcinoma following primary therapy.
Bottles K; Winkler B; Lacey CG; Stern JL; Braga CA; Miller TR
Gynecol Oncol; 1987 Sep; 28(1):68-73. PubMed ID: 3653771
[TBL] [Abstract][Full Text] [Related]
26. Is neoadjuvant chemotherapy followed by radical surgery more effective than radiation therapy for stage IIB cervical cancer?
Lee DW; Lee KH; Lee JW; Park ST; Park JS; Lee HN
Int J Gynecol Cancer; 2013 Sep; 23(7):1303-10. PubMed ID: 23881101
[TBL] [Abstract][Full Text] [Related]
27. Doppler Ultrasound Flow Evaluation of the Uterine Arteries Significantly Correlates with Tumor Size in Cervical Cancer Patients.
Bolla D; In-Albon S; Papadia A; Di Naro E; Gasparri ML; Mueller MM; Raio L
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S959-63. PubMed ID: 26036189
[TBL] [Abstract][Full Text] [Related]
28. [Clinical analysis of 79 cases of cervical cancer].
Cao LQ; Li X; Wu JJ
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2005 Feb; 30(1):119-20. PubMed ID: 15871207
[No Abstract] [Full Text] [Related]
29. [Analysis of the diagnosis and treatment of cervical minimal deviation adenocarcinoma].
Li H; Gou HY; Han JS; Li SM; Yang R; Qiao J
Zhonghua Zhong Liu Za Zhi; 2008 Oct; 30(10):772-4. PubMed ID: 19173810
[TBL] [Abstract][Full Text] [Related]
30. The prognostic factors for locally advanced cervical cancer patients treated by intensity-modulated radiation therapy with concurrent chemotherapy.
Chen CC; Wang L; Lin JC; Jan JS
J Formos Med Assoc; 2015 Mar; 114(3):231-7. PubMed ID: 25777974
[TBL] [Abstract][Full Text] [Related]
31. Squamous cell carcinoma of the head and neck: ESMO clinical recommendations for diagnosis, treatment and follow-up.
; Pivot X; Villanueva C
Ann Oncol; 2007 Apr; 18 Suppl 2():ii65-6. PubMed ID: 17491053
[No Abstract] [Full Text] [Related]
32. Comparing treatment outcomes of stage IIIB cervical cancer patients between those with and without lower third of vaginal invasion.
Katanyoo K
J Gynecol Oncol; 2017 Nov; 28(6):e79. PubMed ID: 29027397
[TBL] [Abstract][Full Text] [Related]
33. [Management of invasive cervical cancer in pregnancy: clinical analysis of 13 cases].
Guo Q; Shan Y; Yang JX; Liu JT; Cao DY; Cheng NH; Huang HF; Pan LY; Lang JH; Shen K
Zhonghua Fu Chan Ke Za Zhi; 2012 Dec; 47(12):893-7. PubMed ID: 23324187
[TBL] [Abstract][Full Text] [Related]
34. [Response to neoadjuvant chemotherapy on locally advanced cervical cancer and long-term follow-up outcome].
Wan T; Huang H; Liu JH; Li Z; Feng YL
Zhonghua Yi Xue Za Zhi; 2010 Nov; 90(43):3045-8. PubMed ID: 21211323
[TBL] [Abstract][Full Text] [Related]
35. Esophageal cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up.
; Stahl M
Ann Oncol; 2007 Apr; 18 Suppl 2():ii15-6. PubMed ID: 17491027
[No Abstract] [Full Text] [Related]
36. [Tumor-associated trypsin inhibitor--an expanded tumor marker spectrum in cervix cancer?].
Medl M; Ogris E; Fuchs G; Leodolter S
Gynakol Rundsch; 1990; 30 Suppl 1():118-21. PubMed ID: 2079243
[No Abstract] [Full Text] [Related]
37. Can we predict vesicovaginal or rectovaginal fistula formation in patients with stage IVA cervical cancer?
Biewenga P; Mutsaerts MA; Stalpers LJ; Buist MR; Schilthuis MS; van der Velden J
Int J Gynecol Cancer; 2010 Apr; 20(3):471-5. PubMed ID: 20375815
[TBL] [Abstract][Full Text] [Related]
38. Pathological Risk Factors and Outcomes in Women With Stage IB2 Cervical Cancer Treated With Primary Radical Surgery Versus Chemoradiotherapy.
Bradbury M; Founta C; Taylor W; Kucukmetin A; Naik R; Ang C
Int J Gynecol Cancer; 2015 Oct; 25(8):1476-83. PubMed ID: 26244756
[TBL] [Abstract][Full Text] [Related]
39. [Intraarterial chemotherapy for cervix neoplasms].
Onose R; Miyagi E; Hirahara F
Nihon Rinsho; 2004 Oct; 62 Suppl 10():196-200. PubMed ID: 15535233
[No Abstract] [Full Text] [Related]
40. [Diagnosis of cervical neoplasm--cytology].
Nishikawa A
Nihon Rinsho; 2004 Oct; 62 Suppl 10():113-8. PubMed ID: 15535217
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
